Search in:

Advanced search

Emerging Microbes & Infections Volume 7, 2018 - Issue 1

Submit an article Journal homepage

Open access

1,972

Views

CrossRef citations to date

Altmetric

Original Articles

Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans

Chen TianDepartment of Infectious Diseases, Nanjing Drum Tower HospitalMedical School of Nanjing University210008NanjingJiangsuChina

Yuxin ChenDepartment of Laboratory Medicine, Nanjing Drum Tower HospitalMedical School of Nanjing University210008NanjingJiangsuChina

Yong LiuDepartment of Experimental Medicine, Nanjing Drum Tower HospitalMedical School of Nanjing University210008NanjingJiangsuChina

Shixia WangDepartment of MedicineUniversity of Massachusetts Medical School01605WorcesterMAUSA

Yang LiDepartment of Infectious Diseases, Nanjing Drum Tower HospitalMedical School of Nanjing University210008NanjingJiangsuChina

Guiyang WangDepartment of Infectious Diseases, Nanjing Drum Tower HospitalMedical School of Nanjing University210008NanjingJiangsuChina

Juan XiaDepartment of Infectious Diseases, Nanjing Drum Tower HospitalMedical School of Nanjing University210008NanjingJiangsuChina

Xiang-an ZhaoDepartment of Infectious Diseases, Nanjing Drum Tower HospitalMedical School of Nanjing University210008NanjingJiangsuChina

http://orcid.org/0000-0001-5571-6477

Rui HuangDepartment of Infectious Diseases, Nanjing Drum Tower HospitalMedical School of Nanjing University210008NanjingJiangsuChina

Shan LuDepartment of MedicineUniversity of Massachusetts Medical School01605WorcesterMAUSACorrespondence[email protected]

Chao WuDepartment of Infectious Diseases, Nanjing Drum Tower HospitalMedical School of Nanjing University210008NanjingJiangsuChinaCorrespondence[email protected]

show all

Pages 1-10 | Received 29 Dec 2017, Accepted 17 Jan 2018, Published online: 16 Feb 2018

Cite this article
https://doi.org/10.1038/s41426-018-0034-0
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

TrepoCChanHLLokAHepatitis B virus infectionLancet2014384 2053 206310.1016/S0140-6736(14)60220-8
PubMed Web of Science ®Google Scholar
LocarniniSHatzakisAChenDSLokAStrategies to control hepatitis B: Public policy, epidemiology, vaccine and drugsJ. Hepatol.201562S768610.1016/j.jhep.2015.01.018
PubMed Web of Science ®Google Scholar
TangCMYauTOYuJManagement of chronic hepatitis B infection: current treatment guidelines, challenges, and new developmentsWorld J. Gastroenterol.2014206262627810.3748/wjg.v20.i20.62624033464
PubMed Web of Science ®Google Scholar
WongVWChanHLChronic hepatitis B: a treatment updateSemin. Liver. Dis.20133312212910.1055/s-0033-1345715
PubMed Web of Science ®Google Scholar
NamgyalPImpact of hepatitis B immunization, Europe and worldwideJ. Hepatol.200339S778210.1016/S0168-8278(03)00269-1
PubMed Web of Science ®Google Scholar
WangFThe long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in ChinaVaccine2015332704270910.1016/j.vaccine.2015.03.064
PubMed Web of Science ®Google Scholar
WernerBGIsolated antibody to hepatitis B surface antigen and response to hepatitis B vaccinationAnn. Intern. Med.198510320120510.7326/0003-4819-103-2-201
PubMed Web of Science ®Google Scholar
ShahHBKoelschKAB-Cell ELISPOT: For the Identification of Antigen-Specific Antibody-Secreting CellsMethods Mol. Biol.2015131241942610.1007/978-1-4939-2694-7_42
PubMedGoogle Scholar
ValatsJCInvestigation of memory B cell responses to hepatitis B surface antigen in health care workers considered as non-responders to vaccinationVaccine2010286411641610.1016/j.vaccine.2010.07.058
PubMed Web of Science ®Google Scholar
YenYHStudy of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan)Liver. Int.2005251162116810.1111/j.1478-3231.2005.01157.x
PubMed Web of Science ®Google Scholar
AverhoffFImmunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infectionAm. J. Prev. Med.1998151810.1016/S0749-3797(98)00003-8
PubMed Web of Science ®Google Scholar
FinkKOrigin and function of circulating plasmablasts during acute viral infectionsFront. Immunol.201237810.3389/fimmu.2012.000783341968
PubMed Web of Science ®Google Scholar
European Association For The Study Of The L..EASL clinical practice guidelines: management of chronic hepatitis B virus infectionJ. Hepatol.20125716718510.1016/j.jhep.2012.02.010
PubMed Web of Science ®Google Scholar
van der MolenRGFunctional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis BHepatology20044073874610.1002/hep.20366
PubMed Web of Science ®Google Scholar
TavakoliSPeripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infectionClin. Exp. Immunol.2008151617010.1111/j.1365-2249.2007.03547.x2276928
PubMed Web of Science ®Google Scholar
Li H. et al. Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection. Gut 2017. 10.1136/gutjnl-2017-314098. [Epub ahead of print]
Google Scholar
CaoZA potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alphaHepatology2017661058106610.1002/hep.29213
PubMed Web of Science ®Google Scholar
ZhangLTfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-alpha therapyMol. Immunol.201673374510.1016/j.molimm.2016.03.011
PubMed Web of Science ®Google Scholar
BelloniLIFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosomeJ. Clin. Invest.201212252953710.1172/JCI588473266786
PubMed Web of Science ®Google Scholar
Brunskole HummelIZitzmannAErlMWenzelJJJilgWCharacteristics of immune memory 10-15 years after primary hepatitis B vaccinationVaccine20163463664210.1016/j.vaccine.2015.12.033
PubMed Web of Science ®Google Scholar
GaraNDurability of antibody response against hepatitis B virus in healthcare workers vaccinated as adultsClin. Infect. Dis.20156050551310.1093/cid/ciu867
PubMed Web of Science ®Google Scholar
TuaillonEDetection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assayJ. Immunol. Methods200631514415210.1016/j.jim.2006.07.016
PubMed Web of Science ®Google Scholar
SchumannAAdoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipientsTransplantation20098710311110.1097/TP.0b013e31818bfc85
PubMed Web of Science ®Google Scholar
LoCMDevelopment of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis BHepatology200337364310.1053/jhep.2003.50035
PubMed Web of Science ®Google Scholar
CornbergMHoner Zu SiederdissenCHBsAg seroclearance with NUCs: rare but importantGut2014631208120910.1136/gutjnl-2013-306221
PubMed Web of Science ®Google Scholar
RoushanMRMohammadpourMBaianyMSoleimaniSBijaniATime to seroconversion of HBsAg to anti-HBs in individuals who lost HBsAg during follow-upEpidemiol. Infect.20161442648265310.1017/S0950268816001217
PubMed Web of Science ®Google Scholar
XuXReversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patientsCell. Mol. Immunol.20151230931610.1038/cmi.2015.254654326
PubMed Web of Science ®Google Scholar
CzerkinskyCCNilssonLANygrenHOuchterlonyOTarkowskiAA solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cellsJ. Immunol. Methods19836510912110.1016/0022-1759(83)90308-3
PubMed Web of Science ®Google Scholar
SugalskiJMRodriguezBMoirSAnthonyDDPeripheral blood B cell subset skewing is associated with altered cell cycling and intrinsic resistance to apoptosis and reflects a state of immune activation in chronic hepatitis C virus infectionJ. Immunol.20101853019302710.4049/jimmunol.10008793805966
PubMed Web of Science ®Google Scholar
BaerJB cell responses to H5 influenza HA in human subjects vaccinated with a drifted variantVaccine20102890791510.1016/j.vaccine.2009.11.002
PubMed Web of Science ®Google Scholar
LuciaMPreformed frequencies of cytomegalovirus (CMV)-specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipientsClin. Infect. Dis.2014591537154510.1093/cid/ciu5894650765
PubMed Web of Science ®Google Scholar
Al TabaaYFunctional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cellsBlood200911360461110.1182/blood-2008-02-136903
PubMed Web of Science ®Google Scholar
LiuLComparison of plaque- and enzyme-linked immunospot-based assays to measure the neutralizing activities of monoclonal antibodies specific to domain III of dengue virus envelope proteinClin. Vaccin. Immunol.201219737810.1128/CVI.05388-11
PubMed Web of Science ®Google Scholar
WalshPNOptimization and qualification of a memory B-cell ELISpot for the detection of vaccine-induced memory responses in HIV vaccine trialsJ. Immunol. Methods2013394849310.1016/j.jim.2013.05.0073736720
PubMed Web of Science ®Google Scholar
BernasconiNLTraggiaiELanzavecchiaAMaintenance of serological memory by polyclonal activation of human memory B cellsScience20022982199220210.1126/science.1076071
PubMed Web of Science ®Google Scholar
JahnmatzMOptimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responsesJ. Immunol. Methods2013391505910.1016/j.jim.2013.02.009
PubMed Web of Science ®Google Scholar
LauGKPeginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis BN. Engl. J. Med.20053522682269510.1056/NEJMoa043470
PubMed Web of Science ®Google Scholar
JanssenHLPegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trialLancet200536512312910.1016/S0140-6736(05)17701-0
PubMed Web of Science ®Google Scholar
MarcellinPPeginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis BN. Engl. J. Med.20043511206121710.1056/NEJMoa040431
PubMed Web of Science ®Google Scholar
BrouwerWPAdding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study)Hepatology2015611512152210.1002/hep.27586
PubMed Web of Science ®Google Scholar
WangYCPredictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysisSci. Rep.2016610.1038/srep296054941731
Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date